Clinical Characteristics and Myocardium/LA Chamber Ratio of 11C-DAG of Post-MI Patients and Healthy Volunteers
| Subject no. | Age (y) | Sex | Period after MI (mo) | CK maximum (IU/L) | BNP (pg/mL) | LVEF (%) | LVEDVI (mL/m2) | Medication (per day) | 11C-DAG counts (cps/MBq/kg) | Myocardium/LA chamber ratio of 11C-DAG | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| In LV myocardium | In LA chamber | |||||||||||||||||||||
| Post-MI patients | ||||||||||||||||||||||
| 1 | 66 | F | 31 | 6,794 | 128 | 27 | 81 | Lisinopril (5 mg), metoprolol (120 mg) | 40.5 | 23.9 | 1.69 | |||||||||||
| 2 | 69 | M | 7 | 9,267 | 210 | 19 | 90 | Imidapril (5 mg), carvedilol (10 mg) | 32.9 | 16.3 | 2.01 | |||||||||||
| 3 | 79 | M | 4 | 5,330 | 130 | 33 | 56 | Lisinopril (10 mg), bisoprolol (2.5 mg) | 19.7 | 13.5 | 1.46 | |||||||||||
| 4 | 62 | F | 53 | NA | 599 | 21 | 178 | Imidapril (5 mg) | 52.3 | 20.3 | 2.58 | |||||||||||
| 5 | 72 | M | 42 | 8,122 | 127 | 29 | 82 | Enalapril (2.5 mg) | 31.3 | 17.0 | 1.84 | |||||||||||
| 6 | 58 | F | 7 | NA | 46 | 37 | 61 | None | 26.6 | 19.1 | 1.39 | |||||||||||
| 7 | 71 | F | 11 | 4,191 | 50 | 37 | 60 | Temocapril (4 mg) | 26.4 | 17.0 | 1.56 | |||||||||||
| 8 | 66 | M | 35 | 11,789 | 149 | 37 | 123 | None | 36.2 | 23.7 | 1.52 | |||||||||||
| 9 | 58 | F | 12 | 12,000 | 221 | 19 | 143 | Cadesartan (4 mg), carvedilol (15 mg) | 63.5 | 30.0 | 2.12 | |||||||||||
| 10 | 76 | M | 15 | 1,312 | 84 | 46 | 79 | Enalapril (5 mg), metoprolol (80 mg) | 56.3 | 42.1 | 1.34 | |||||||||||
| 11 | 74 | M | 7 | 1,854 | 99 | 48 | 58 | Enalapril (2.5 mg), metoprolol (60 mg) | 58.9 | 35.5 | 1.66 | |||||||||||
| 12 | 62 | F | 23 | 3,223 | 11 | 51 | 74 | None | 26.5 | 17.4 | 1.53 | |||||||||||
| 13 | 72 | M | 8 | NA | 45 | 43 | 81 | Temocapril (2 mg), metoprolol (60 mg) | 46.7 | 25.6 | 1.82 | |||||||||||
| Mean | 68 | 20 | 6,388 | 146 | 34 | 90 | 39.8 | 23.2 | 1.73 | |||||||||||||
| SD | 7 | 16 | 3,865 | 150 | 11 | 37 | 14.3 | 8.3 | 0.35 | |||||||||||||
| Healthy volunteers | ||||||||||||||||||||||
| 14 | 24 | M | NA | NA | NA | NA | None | 24.1 | 18.8 | 1.28 | ||||||||||||
| 15 | 24 | M | NA | NA | NA | NA | None | 23.3 | 21.7 | 1.08 | ||||||||||||
| 16 | 34 | M | NA | NA | NA | NA | None | 27.3 | 19.8 | 1.38 | ||||||||||||
| 17 | 23 | M | NA | NA | NA | NA | None | 23.9 | 18.9 | 1.26 | ||||||||||||
| Mean | 26 | 24.7 | 19.8 | 1.25 | ||||||||||||||||||
| SD | 5 | 1.8 | 1.3 | 0.13 | ||||||||||||||||||
LA = left atrium; CK = creatine kinase; BNP = brain natriuretic peptide; LVEF = LV ejection fraction; LVEDVI = LV end-diastolic volume index; NA = not available.